Vial and closure specificationsComponent fit and inspectionMoisture and material evidenceTransport protection

Plan Container Closure Integrity Assessment

Container closure integrity concerns the ability of a package system to maintain its protective barrier under the conditions being assessed. A seal that looks intact is not by itself evidence of that performance.

Define the package and the question

Container closure integrity concerns the ability of a package system to maintain its protective barrier under the conditions being assessed. A seal that looks intact is not by itself evidence of that performance. The evaluation should identify the package, process state, relevant conditions and the method used to investigate the question.

Do not infer integrity from appearance

FDA guidance discusses integrity testing within defined stability-program contexts for sterile products. Its scope should be understood before using it as a technical reference for a different project. It does not establish that a cosmetic or research package is sterile or validated. Ask a qualified provider to propose a suitable assessment for the actual configuration. Keep method limitations and acceptance criteria visible in the report. A conclusion should apply to the tested system and conditions rather than become a broad claim about every vial or stopper carrying the same trade name.

Define the integrity question in product context

Container closure integrity concerns the ability of the assembled system to maintain the required barrier under defined conditions. The relevant question depends on the product and intended use. A package may need assessment after assembly, processing, storage or a transport challenge. Identify which stage and which configuration the evidence will address. Avoid treating an isolated measurement on an empty demonstration package as a complete conclusion about a different filled presentation or a different set of exposure conditions.

Select methods through technical justification

Different methods rely on different physical principles and have different applicability, sensitivity and practical constraints. A suitable method must be assessed for the package, contents and intended question. The responsible laboratory or specialist should define controls, method suitability and the basis for interpreting results. Buyers can request this rationale without selecting operating parameters themselves. The important distinction is between a method being generally available and that method being suitable for the specific system and decision under review.

Keep the conclusion within the evaluated boundary

A report should identify components, sample condition, method, challenge conditions if any, and acceptance basis. State whether the work supports a particular configuration at a particular stage or a wider claim backed by an appropriate program. Changes in materials, dimensions or assembly can require review of applicability. Closure-integrity evidence also does not automatically answer every question about chemical interaction or product stability. Keep those evidence streams connected in the project record while preserving the different questions each one addresses.

Request a Vial Packaging Review

Share component drawings, expected assembly state, intended topical cosmetic format and the packaging decision under review.